Excellent Outcome with comparable pain after Enhanced Recovery Total Hip Arthroplasty (ERAS-THA) versus a conventional setup: The First Prospective Single Blinded Randomized Clinical Trial (RCT)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00031345

Enrollment

200

Registered

2023-02-27

Start date

2019-07-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M16.1

Interventions

Group 1: ERAS THA Group 2: Conventional THA

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: elective primary THA due to primary or secondary osteoarthritis

Exclusion criteria

Exclusion criteria: severe dysplasia of the hip, use of other prosthetic components, severe obesity (body mass index (BMI) > 40 kg/m2), malignancy, condition following deep vein thrombosis, therapeutic anticoagulation, immobility with preoperative walking distance <100m with forearm crutch or wheeled walker, a prior fracture within the surgical region, open pre-surgery, simultaneous participation in another study or refusal by the subject

Design outcomes

Primary

Measure	Time frame
TUG-Score preoperatively and daily regarding inpatient care	—

Secondary

Measure	Time frame
floor count and walking distance in meters as well as rest, mobilization and night pain on a numerous rating scale (NRS). To assess and compare clinical outcome and patient satisfaction, the PPP33-Score and PROMs were used.	—

Countries

Germany

Contacts

Public ContactFelix Greimel

Orthopädische Uniklinik Regensburg

Felix.greimel@ukr.de09405182478

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026